An official website of the United States government.

This is not the current EPA website. To navigate to the current EPA website, please go to www.epa.gov. This website is historical material reflecting the EPA website as it existed on January 19, 2021. This website is no longer updated and links to external websites and some internal pages may not work. More information »

PRIA Fee Category Table - Antimicrobial Division - Experimental Use Permits and Other Actions

Table 10.

EPA No. New CR No. Action Decision Review Time (Months) (1) FY'20 - FY'21 Fees ($)
A520 94 Experimental Use Permit application, non-food use (2) 9 6,703
A521 95 Review of public health efficacy study protocol within AD, per AD Internal Guidance for the Efficacy Protocol Review Process; Code will also include review of public health efficacy study protocol and data review for devices making pesticidal claims; applicant-initiated; Tier 1 4 4,963
A522 96 Review of public health efficacy study protocol outside AD by members of AD Efficacy Protocol Review Expert Panel; Code will also include review of public health efficacy study protocol and data review for devices making pesticidal claims; applicant-initiated; Tier 2 12 12,764
A537 97 (new) New Active Ingredient/New Use, Experimental Use Permit application; Direct food use; Establish tolerance or tolerance exemption if required. Credit 45% of fee toward new active ingredient/new use application that follows. 18 160,814
A538 98 (new) New Active Ingredient/New Use, Experimental Use Permit application; Indirect food use; Establish tolerance or tolerance exemption if required Credit 45% of fee toward new active ingredient/new use application that follows. 18 100,511
A539 99 (new) New Active Ingredient/New Use, Experimental Use Permit application; Nonfood use. Credit 45% of fee toward new active ingredient/new use application that follows. 15 96,772
A529 100 Amendment to Experimental Use Permit; requires data review or risk assessment (2) 9 12,001
A523 101 Review of protocol other than a public health efficacy study (i.e., Toxicology or Exposure Protocols) 9 12,764
A571 102 Science reassessment: Cancer risk, refined ecological risk, and/or endangered species; applicant-initiated. 18 100,511
A533 103 (new) Exemption from the requirement of an Experimental Use Permit (2) 4 2,607
A534 104 (new) Rebuttal of agency reviewed protocol, applicant initiated 4 4,963
A535 105 (new) Conditional Ruling on Pre-application Study Waiver or Data Bridging Argument; applicant-initiated 6 2,530
A536 106 (new) Conditional Ruling on Pre-application Direct Food, Indirect Food, Nonfood use determination; applicant-initiated 4 2,607

1A decision review time that would otherwise end on a Saturday, Sunday, or federal holiday, will be extended to end on the next business day.

2Where the action involves approval of a new or amended label, on or before the end date of the decision review time, the Agency shall provide to the applicant a draft accepted label, including any changes made by the Agency that differ from the applicant-submitted label and relevant supporting data reviewed by the Agency. The applicant will notify the Agency that the applicant either (a) agrees to all of the terms associated with the draft accepted label as amended by the Agency and requests that it be issued as the accepted final Agency-stamped label; or (b) does not agree to one or more of the terms of the draft accepted label as amended by the Agency and requests additional time to resolve the difference(s); or (c) withdraws the application without prejudice for subsequent resubmission, but forfeits the associated registration service fee. For cases described in (b), the applicant shall have up to 30 calendar days to reach agreement with the Agency on the final terms of the Agency-accepted label. If the applicant agrees to all of the terms of the accepted label as in (a), including upon resolution of differences in (b), the Agency shall provide an accepted final Agency-stamped label to the registrant within 2 business days following the registrant’s written or electronic confirmation of agreement to the Agency.